A case of blood triglyceride increased induced by ABVD therapy for classical Hodgkin lymphoma

Bonadonna, 1975, Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP, Cancer, 36, 252, 10.1002/1097-0142(197507)36:1<252::AID-CNCR2820360128>3.0.CO;2-7 Federico, 2009, ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial, J. Clin. Oncol., 27, 805, 10.1200/JCO.2008.17.0910 Martin, 2005, Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma, J. Clin. Oncol., 23, 7614, 10.1200/JCO.2005.02.7243 Duman, 2012, Capecitabine-induced hypertriglyceridemia and hyperglycemia: two cases, Pharmacology, 90, 212, 10.1159/000342382 Polinder-Bos, 2012, Severe hypertriglyceridaemia associated with the use of capecitabine, Neth. J. Med., 70, 104 Pejic, 2006, Hypertriglyceridemia, J. Am. Board Fam. Med., 19, 310, 10.3122/jabfm.19.3.310 Saito, 2021, Severe hypertriglyceridemia induced by docetaxel: a novel case report, Case Rep. Oncol., 14, 1277, 10.1159/000518684 Naranjo, 1981, A method for estimating the probability of adverse drug reactions, Clin. Pharmacol. Ther., 30, 239, 10.1038/clpt.1981.154 He, 2020, Adjuvant chemotherapy-associated lipid changes in breast cancer patients: a real-world retrospective analysis, Med. (Baltim.), 99, e21498, 10.1097/MD.0000000000021498 Aluise, 2011, 2-mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-α release: implications for the reactive oxygen species-mediated mechanisms of chemobrain, Free Radic, Biol. Med., 50, 1630